Le Lézard
Classified in: Health
Subjects: NPT, SVY, POL, AVO

Poll: 86% Of Voters Oppose Taxing Employer-Provided Health Insurance


WASHINGTON, July 16, 2019 /PRNewswire/ -- A new poll, conducted July 12, 2019 by pollster Frank Luntz, highlights 86% of voters oppose taxes on employer-provided health care coverage.  

The Alliance to Fight the 40|Don't Tax My Health Care is a broad-based coalition comprised of businesses, patient advocates, employer organizations, unions, local governments, health care companies, consumer groups and other stakeholders that support employer-provided health coverage. This coverage is the backbone of our health care system and protects over 178 million Americans. The Alliance seeks to repeal the 40%

Health care continues to be the No. 1 concern for voters, beating out immigration, climate change, the federal debt, and trade as the top issue. Employers provide access to health care coverage to more than half of all Americans, but this coverage is threatened by the looming 40% "Cadillac Tax" on job-based health care. This new poll finds that 76% of voters want to protect and strengthen the employer-provided coverage that either they, or their family, depend on, rather than eliminating it.

The U.S. House of Representatives has set a Wednesday, July 17 vote on H.R. 748, the bipartisan "Middle Class Health Benefits Tax Repeal Act of 2019," to fully repeal the 40% "Cadillac Tax" on employer-provided health care coverage, led by Reps. Joe Courtney (D-CT) and Mike Kelly (R-PA). This legislation has 367 cosponsors and strong bipartisan support.

"More than 181 million people receive health care coverage from an employer ? coverage that they like and want to keep," said James A. Klein, president of the American Benefits Council. "Tomorrow, Congress will have an opportunity to show voters that they will protect this coverage by fully repealing the 'Cadillac Tax,' which is already leading to higher deductibles and increased out-of-pocket costs for working Americans. Health care coverage is not a luxury good, and it shouldn't be taxed that way."

The employer-provided health care system is stable, efficient, affordable, and effective in covering more than half of All Americans. Let's work together to protect what works and keep health care affordable. #DontTaxMyHealthCare

The Alliance to Fight the 40|Don't Tax My Health Care is a broad-based coalition comprised of businesses, patient advocates, employer organizations, unions, local governments, health care companies, consumer groups and other stakeholders that support employer-provided health coverage. This coverage is the backbone of our health care system and protects more than 181 million Americans. The Alliance seeks to repeal the 40% "Cadillac Tax" on health benefits and to prevent increased income taxes on workers, families and retirees who rely on employer-provided health coverage. The Alliance is committed to ensuring that employer-provided coverage remains an effective and affordable option for working Americans and their families. 

Contact: Tara Bradshaw
202-441-8255

SOURCE Alliance to Fight the 40


These press releases may also interest you

at 08:15
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that it will be attending the LSX World Congress (29-30 April) and presenting at Bio?quity Europe (12-14 May). The...

at 08:15
Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a potential new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple presentations highlighting positive efficacy and safety...

at 08:15
Nuvation Bio Inc. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of Colleen Sjogren as Chief Commercial Officer. Ms....

at 08:10
Edgewise Therapeutics, Inc. , a leading muscle disease biopharmaceutical company, today announced that the Company will present data on EDG-7500 at the American College of Cardiology's Annual Scientific Session (ACC.24). EDG-7500 is a first-in-class...

at 08:05
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a new Human Pangenome Spike-in for the Twist Exome 2.0 panel developed...

at 08:05
Bio-K Plus, a Kerry Company, pioneer in the probiotic sector, is pleased to announce the launch of its new functional drinkable probiotic, the Extra Stress Support with Sensoril®....



News published on and distributed by: